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ABSTRACT
STRUCTURE-SUBSTRATE BINDING RELATIONSHIPS 
OF HIV-1 REVERSE TRANSCRIPTASE
Steve Chien-Wen Huang
Old Dominion University 
and
Eastern Virginia Medical School 
1994
Director: Dr. Laura K. Moen
Human Immunodeficiency Virus, type 1 (HIV-1), is the causative agent of the 
Acquired Immunodeficiency Syndrome (AIDS). HIV-1 reverse transcriptase (RT), 
a heterodimer p66/p51, has been the major target for treatment of AIDS. The 
significance of the p51 subunit and the RNase H domain of p66 in terms of their 
influence on the RNA-dependent DNA synthesis was investigated. Clones of the 
wildtype HIV-1 RT subunits, p66 and p51, and a recombinant C-terminal deletion 
mutant, p64, [Barr, P. J. (1987) Bio/Technoloav 5, 486-489] were employed to 
study the structure-substrate binding relationships of HIV-1 RT. The activity 
assays of RNA-dependent DNA synthesis on both poly(rA)(dT) and a random 
base RNA template hybridized with a DNA oligomer showed that p51 significantly 
affects the enzyme activity. The increase in processivity by p51 in the p66/p51 
heterodimer was also demonstrated. These observations suggested that the 
integrity of p51 is important in subunit-interactions for maintaining a favorable 
conformation of the enzyme for optimal function. C-terminal deletion in p66 was 
seen to decrease the processivity. The dissociation constant (Kd) for poly(rA)(dT) 
obtained by nitrocellulose binding assays suggested that the processivity of HIV-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1 RT on poly(rA)(dT) correlated with the affinity for the substrate. The 
processivity of RT on RNA335-DNA20 was seen to be affected by the pause 
sites observed on the autoradiograms. The pauses of DNA synthesis tended to 
occur at positions of template containing poly G-C sequences. The order of 
processivity observed on RNA335-DNA20 was p64/p64, p66/p66 < p64/p51 < 
p66/p51. The C-terminal deletion in p66 was shown to affect the ability to extend 
the DNA strand on RNA template. In those non-wildtype forms of HIV-1 RT 
(p66/p66, p64/p64, and p64/p51), the affinity for primer-template seemed to be 
sensitive to the structure of the RNA template as seen when comparing Kds 
between poly(rA)(dT) and RNA335-DNA20. The wildtype enzyme, p66/p51, 
appeared to have a similar affinity for both substrates.
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I. Introduction
Human Immunodeficiency Virus, type 1 (HIV-1), is thought to be the 
causative agent of the Acquired Immunodeficiency Syndrome (AIDS) (1-5). HIV- 
1 reverse transcriptase (RT), an important viral enzyme responsible for 
converting the viral RNA genome into viral DNA after infection, has been the 
major target for treatment of AIDS (6-19). Although many inhibitors are known, 
such as 3'-azido-3'deoxythymidine (AZT), ddC and ddl which are 
dideoxymononucleoside analogs that cause chain termination during DNA 
polymerization, the use of these drugs is compounded by serious side effects 
such as bone marrow suppression, resumption of virus replication during therapy, 
and emergence of AZT-resistant HIV-1 mutants (20-22). Deeper knowledge 
regarding the molecular structure of this enzyme along with its enzymatic 
mechanism is highly desirable to develop a better drug design.
History of HIV (1-5)
AIDS, an infectious disease spread by blood, by sexual intercourse, and 
from mother to child, has become an epidemic since the first AIDS cases were 
diagnosed in 1981 among young homosexual men in the U.S. HIV was 
discovered to be the causative agent during the two years from mid-1982 to mid- 
1984 (5). It was first observed that all AIDS victims suffered from a depletion of 
T4 cells, a specific subset of T cells. And it was suspected that a species of 
retrovirus, like HTLV-I which can infect T lymphocytes and cause highly
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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malignant cancer, was the pathogen. The evidence started with the finding that 
the reverse transcriptase activity, a main characteristic of retroviruses, was 
detected in the swollen lymph node of a young homosexual (5). This pathogen 
was identified as a new retrovirus. This new virus was found to grow only in T4 
cells and not in the related cells called T8. Electron micrographs of the new virus 
were different from those of HTLV-I. Also, a viral protein p25 (or p24) found in 
the AIDS pathogen was not present in HTLV-I. A blood test was eventually 
formulated to show that this new virus was present in almost all people with 
AIDS, in a variable proportion of people who had received blood contaminated by 
the virus, and in no healthy heterosexuals (5). It was then firmly established that 
the new virus is the cause of AIDS and the virus was named as Human 
Immunodeficiency Virus, HIV.
Life cycle of HIV
HIV was later found to infect not only T4 cells but also macrophages (23). 
HIV enters its target cells by interacting with the molecule called CD4 (23). CD4 
has a significant role in the immune function of T4 lymphocytes and is also found 
in the smaller numbers on some macrophages, allowing them to be infected. The 
life cycle of HIV is shown in Figure 1. The genes of a retrovirus are encoded as 
RNA. The cycle begins when an HIV particle binds to the outside of a cell and 
injects its core (23). The core includes two identical strands of RNA as well as 
structural proteins and enzymes. One enzyme, called reverse transcriptase, is 
responsible for converting the viral genetic information into DNA. The enzyme 
first makes a single-stranded DNA copy of the viral RNA, destroys the original 
RNA, and then makes a second DNA copy using the first one as the template 
(23). The viral genetic information, now in the form of double-stranded DNA, 
migrates to the cell nucleus. A second viral enzyme, called integrase, splices the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 1 Life cycle of HIV. HIV infection begins when a virion, or virus particle, 
binds to the outside of a susceptible cell by the interaction between viral GP120 
and host CD4 proteins. The virion then fuses with the cell, injecting the core 
proteins and two strands of RNA. The double-stranded DNA, synthesized by viral 
reverse transcriptase on the RNA genome, migrates to the nucleus and is 
integrated into the cell's own DNA. The provirus can then remain latent, giving no 
sign of its presence. Alternatively, it can commandeer the cellular mechanism to 
transcribe its genes into RNA, some of which are translated into proteins on 
ribosome. The proteins and the RNA genome are then assembled into new 
virions that bud from the cell (23).
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HIV genome into the host cell DNA. The viral DNA will be duplicated with the 
cell's own genes every time the cell divides (23). The expression of the viral 
genes is regulated by the nucleotide sequence in the so-called long terminal 
repeats (LTR's) (23). LTR's are stretches of DNA at the ends of the viral genome 
which can direct enzymes belonging to the host cell to copy the proviral DNA into 
RNA. Some of the RNA will provide the genetic material for a new generation of 
virus. Certain other RNA strands serve as the mRNA's that guide cellular 
machinery in producing the structural proteins and enzymes of the new virus. 
Two different protein molecules in a ratio of about 20 to one will be assembled 
with the RNA genome (23). The more abundant molecule (gag ) is the precursor 
of the protein shell that will enclose the RNA and enzyme in the complete virions. 
The other molecule (gag-pol) is larger; it contains the same structural 
components but includes additional segments that will become the viral enzymes. 
The two proteins migrate to the periphery of the cell as they are produced, a fatty 
acid at the end of each one attaches it to the inside of the cell membrane. As 
these precursors aggregate, they bind to one another and form a spherical 
structure that bulges outward under the cell membrane. Two strands of the viral 
RNA are drawn into this nascent virion as it takes shape. One of the enzymes 
contained in the gag-pol precursor, the viral protease, cuts itself free of the 
protein chain and cleaves the reverse transcriptase, the integrase and the 
additional molecules of protease. It then cleaves the gag polypeptides and what 
is left of the gag-pol polypeptides into four segments each. Three of the 
segments collapse to form a bullet-shape core surrounding the RNA and 
enzymes but the remaining segments stay attached to the inside of the cell 
membrane. The viral envelope proteins, which jut from the membrane like a set 
of spikes are made and transported to the cell surface independently of the core 
proteins. Each spike is a complex of two or three identical units that in turn
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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consist of two components: gp120 and gp41. These glycoprotein complexes are 
crucial to HIV's ability to infect new cells. The virions will sweep up the cell 
membrane with envelope proteins to enclose the core and release from the host.
Current therapeutic methods of RT inhibition
HIV-1 RT is responsible for converting the viral RNA into DNA and hence is 
the major target for antiviral treatment. Most of the effective inhibitors of HIV-1 
RT are nucleoside analogs, the 2',3'-dideoxynucleosides, including AZT (20-22). 
These dideoxynucleosides are missing the 3-hydroxyl which is required for 
further deoxynucleoside monophosphate (dNMP) incorporation. It is observed 
that HIV-1 RT has a higher affinity for dideoxynucleotides than for normal 
substrates (22). They inhibit HIV-1 RT after they are metabolized in vivo to the 
appropriate triphosphates by terminating the DNA chain growth. Unfortunately, 
all of these compounds have toxicities that limit their usefulness in the treatment 
for AIDS. For example, the most frequent toxicity of AZT is bone marrow 
suppression. In addition, the emergence of the drug resistant strains is 
observed. Comparative nucleotide sequence analysis of the reverse 
transcriptase-coding region from AZT sensitive and resistant isolates reveals four 
common amino acid substitutions: Asp67Asn, Lys70Arg, Thr215Phe, and 
Lys219Gln (22).
A variety of benzodiazepine and dipyridodiazepine derivatives have been 
identified as potent antiviral agents inhibiting HIV-1 RT as non-nucleoside analog 
inhibitors (50, 68, 69). Most appear to bind to a site on HIV-1 RT near T y r l81 
which is distinct from the substrate binding site. Unlike the dideoxynucleoside 
analogs that can inhibit a number of human and animal retroviral DNA 
polymerases, these two groups of compounds are highly specific to HIV-1 RT. 
Several drugs selected from these two groups are under preclinical or clinical
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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development. One of these non-nucleoside analogs, Nevirapine, is found to bind 
in a deep pocket that lies between beta sheet of the palm and the base of the 
thumb (50). It has been suggested that the binding of Nevirapine could prevent 
the movement of the thumb subdomain relative to the thumb subdomain during 
DNA synthesis or affect the conformation of the active site.
Despite intensive research efforts to identify compounds which inhibit HIV-1 
RT, only AZT and ddl have been licensed to date for the treatment for HIV-1 
infection. There is still great need to develop new drugs that have less 
cytotoxicity and are active against viral isolates resistant to AZT or ddl. Deeper 
knowledge about the structure and function relationships of HIV-1 RT is highly 
desirable for the development of more specific inhibitors.
Structure of HIV-1 RT
As shown in Figure 2, HIV-1 RT is encoded by gag-pol mRNA where the 5' 
end of the po/open reading frame overlaps the 31 end of gag with the po/frame 
by one nucleotide in the 51 direction (-1) (24). Ribosome frame-shifting is utilized 
to produce the gag-pol polypeptide which, in turn, gives rise to HIV-1 RT. In 
both virions and infected cells, HIV-1 RT has been characterized as a 
heterodimer consisting of two subunits: p66 and p51 (25-30). The two subunits 
have identical amino termini because p51 is derived by proteolytic processing of 
p66 by the viral protease with the cleavage site at Phe440-Tyr441 (31-35). It has 
been determined that the DNA polymerase and RNase H activities of HIV-1 RT 
map to the amino- and carboxyl- terminal portions connection region called the 
tether domain (28, 41, 46, 47). The p51 subunit lacks the RNase H domain. It 
has been reported that enzymatic activity is almost exclusively confined to the 
dimeric form of the enzyme and only one primer-template binding site is present 
in a dimer (48, 49). It has also been shown that the p66 subunit provides the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 2 Schematic representation of the pol gene of H I\M  RT and its 
relationship to protease, RT and integrase.
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polymerization active site in the p66/p51 heterodimer (49). According to the 
crystal structure, the p66 subunit is folded into five separate regions: the RNase 
H domain, the connection domain, and three subdomains of the pol domain, 
namely fingers , palm, and thumb (50, Figure 3). The p66 subunit is highly 
elongated in folding, having dimensions of approximately 110 by 30 by 45 A0, and 
a cleft is formed by the finger, palm, and thumb subdomains (50). The 
conformation of p51 is astonishingly different from that of p66, although both bear 
the same amino acid sequences (50). Unlike p66, p51 has no cleft, and residues 
thought to be involved in catalysis (Asp185, Asp186, Asp110) are essentially 
buried (50). The thumb domain is further from the fingers and palm subdomains. 
The connection domain lies within and fills the expanded cleft (50). The tip of the 
fingers and the connection domain of p51 interact with the palm and connection 
sudomains of p66 (50). The extended thumb of p51 contacts the RNase H 
domain of p66 (50). The crystal structure of HIV-1 RT implies that one of the p66 
subunits of the p66/p66 homodimer should assume the conformation of p51 and 
unravel its RNase H domain for cleavage (50).
Function of HIV-1 RT
HIV-1 RT can polymerize a DNA strand from either an RNA or a DNA 
template. The enzyme also encodes an RNase H activity that hydrolyzes the 
RNA of RNA-DNA duplexes (51-57). As shown in Figure 4, the primer for minus 
strand DNA synthesis is a specific tRNA(*-ys) molecule that is packaged in the 
virion and base paired to the primer-binding site (PBS) located near the 5' end of 
the RNA genome (58). Synthesis of the minus strand is initiated from the 3‘ end 
of the tRNA molecule and continued to the end of the viral genome. The 
hybridized RNA ( R and U5 sequences) is removed and the short DNA minus 
strand is translocated to the 3' end of the same or a second RNA molecule,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 3 A stereo a-carbon model of p66/p51. The p66 subunit is in blue 
color. The fingers, thumb, palm, connection, and RNase H subdomains are 
indicated by arrows. Residues 539 - 560 of p66 (the region deleted in p64) are 
shown in green. The p51 subunit is in white color. The double helix in red is the 
template-primer. Model was generated with SYBYL on a Silicon Graphics 
computer from the a-carbon coordinates reported by [Arnold, E. et al. (1992) 
Nature 357. 85-89],
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Figure 4 The process of reverse transcription by HIV-1 RT (58).
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By reconstituting p66, p51, and p64, we have been able to use four forms 
of enzymes for structure-function study. One form, p66/p51, is the wildtype 
heterodimer. Another, p66/p66, is the homodimer which contains an extra 
RNase H domain (p15) in the non-catalytic subunit. The mutant heterodimer, 
p64/p51, has 22 amino acid residues deleted in the C-terminus and lacks the 
RNase H function, and p64/p64 is the mutant homodimer that contains C- 
terminal deletion at p66 and has an extra stretch of polypeptide in the non- 
catalytic subunit.
The activity assays of RNA-dependent DNA synthesis on both poly(rA)(dT) 
and RNA335-DNA20 demonstrated that the replacement of p51 for the non- 
catalytic subunit significantly increases the enzyme activity (Figure 12, 13, 20, 
and 21). The results showed that the conditions used for reconstitution in this 
study favor the formation of a more active enzyme, the heterodimer. This result 
was supported by the observation that the enzyme activity is exclusively confined 
to the dimer forms in an investigation of the process of dimer formation and the 
properties of the different mono- and dimeric forms of HIV-1 RT (28, 93). Also, it 
has been shown that individually purified p66 and p51 were capable of binding to 
form 1 : 1 heterodimer with an association constant 10-fold greater than that 
observed for p66/p66 homodimer formation (101).
The reconstituted heterodimer, in both wildtype and mutant, was shown to 
have better processivity on poly(rA)(dT) (Figures 14 -17). Since monomeric p66 
has little activity (28, 93), these increases in enzyme activity and processivity 
suggested that the p51 polypeptide has an important role in the enzyme structure 
and function. One possible role could be that p51 improves the enzyme 
processivity through its contribution to a better primer-template interaction and/or 
a better conformation of the enzyme active site. The primer-template interaction 
with the enzyme was hence investigated.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 5 DNA polymerase mechanism of HIV-1 RT. A bireactant biproduct 
mechanism has been proposed for DNA synthesis by HIV-1 RT. In this 
mechanism, binding of the reactants is ordered with the primer-template binding 
first followed by the binding of the dNTP that is complementary to the next 
appropriate template residue. The incorporation of dNMP into the nascent chain 
then occurs via an Sn2 displacement of pyrophosphate (the first product) of the 
dNTP by the 3' hydroxyl at the primer terminus. Multiple dNMP additions can 
occur before the enzyme dissociates from the extended primer-template, the 
second product.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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pyrophosphate (the first product) of the dNTP by the 3' hydroxyl at the primer 
terminus. Multiple dNMP additions can occur before the enzyme dissociates 
from the extended primer-template, the second product. HIV-1 RT is highly error- 
prone and produces approximately 5 to 10 nucleotide errors per genome every 
round of replication in vivo (67). This high error rate of HIV-1 RT is believed to be 
responsible for the hypermutability of HIV (67).
The RNase H domain of HIV-1 RT was assigned to the residues Glu348 
through Ile559 of the polypeptide (47). Asp443, Glu478, Asp498, and Asp549 
were suggested to be important in RNase H activity (98). The HIV-1 RT RNase 
H domain was found to display both endonuclease and 3' to 5' exonuclease 
activities (86). The distance between the RNase H and polymerase active sites 
was found to correspond to the length of a 15-16 nucleotide DNA-RNA 
heteroduplex (99). Also, it was found that the RNase H function is much less 
active than the polymerase function during processive DNA synthesis (87). The 
endonuclease function of RNase H domain was found to be in the direction of 3' 
to 5' and displayed a partially processive activity. The RNase H domain 
expressed in bacteria was found to be inactive by itself, and the addition of the 
p51 polypeptide led to enzymatic activity (84). This observation suggested the 
interdependence of polymerase and RNase H domains.
Interaction between HIV-1 RT and primer-template
In the crystal structure of HIV-1 RT, an obvious groove which exists 
between the RNase H domain and polymerase domain is presumably the primer- 
template binding site (50). DNA synthesis on an RNA template by HIV-1 RT is 
accompanied by the cleavage of the RNA template by RNase H; the RNase H 
cleavage site has been estimated to be some 15 to 16 nucleotides downstream
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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of the synthesis. Thus, the RNA-DNA duplex of the primer-template must lie 
between these two active sites with the 3' end of the RNA contacting the RNase 
H active site marked by the binding of the divalent cations in the crystal structure, 
and the 3' end of the DNA of the duplex in contact with the DNA polymerase 
active site. In a fitting m ode l, the RNA-DNA can be fit snugly into the groove 
observed in the crystal structure when the DNA is modestly bent toward the 
protein. The cross-linking of dT15 to HIV-1 RT homodimers showed the cross­
links at residues Leu289 to Thr290 and Leu295 to Thr296 which are in the thumb 
subdomain (69). It is also reported that the N-terminus of residues 1 to 230 of 
HIV-1 RT is capable of nucleic acid binding (70). The location of p51 relative to 
the RNA-DNA-HIV-1 RT fitting model suggests that the connection domain of p51 
has a possible role in binding the tRNA-template complex by contacting the 
duplex as well as the eighteen anticodon and D stems and loops of tRNA (50).
Steady-state analyses have been performed on HIV-1 RT to determine the 
dissociation constant for primer-template. A summary of the measured 
dissociation constants of the wild-type HIV-1 RT (p66/p51) for primer-template is 
given in Table 1. Huber et al. (67) have demonstrated that HIV-1 RT forms a 
stable complex with poly(rA)(dT) primer-template in the absence of Mg~ and 
dTTP with a Kd of 3 nM. Krug et al. (63) have used globin mRNA hybridized to 
dT15 and demonstrated that Kd calculated by Scatchard method is 11 nM. The 
amount of globin mRNA-dT bound to the enzyme is obtained by extrapolating the 
burst of incorporation at zero time. Reardon's studies (71) have revealed a Kd 
of 10 nM for HIV-1 RT binding to a template-primer (RNA44-DNA21) by 
measuring the burst of product formation upon addition of dTTP. Kati etal. (72) 
have used rapid transient kinetic method with defined synthetic RNA45-DNA25 to 
obtain a Kd of 10 nM for the interaction between HIV-1 RT and this template- 
primer. Hsieh etal. (73), using a quadratic binding equation: [E.D] = 0.5 ([E]t+
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 1 Summary of the measured dissociation constants of HIV-1 RT 
(p66/p51) for primer-template.
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Author Huber Krug Reardon Kati Hsieh Beard
primer-
template rAdT mRNAdT r44/d21 r45/d25 d32/d23 rAdT
Reference 67 63 71 72 73 74
Kd(nM) 3 11 10 26 15 < 1
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[D]t + Kd) - 0.5 ( [E],+ [D], + Kd) 2 - 4 [E], [D], )1/2> have obtained a Kd of 26 nM 
for the interaction between HIV-1 RT and a DNA32-DNA23 template-primer. 
Binding of this 23/32-mer primer-template by HIV-1 RT was also examined by the 
gel mobility shift assay and results fit to a hyperbolic binding cun/e with Kd of 15 
nM. Beard et al. (74) have used a template-primer challenge assay to 
quantitatively follow RT-template-primer complex formation and observed that 
HIV-1 RT ( both p66/p66 and p66/p51) bind to poly (rA)(dT)16 tightly with a Kd < 1 
nM. As shown in Table 1 all the values are in nM range. Also, the Kd for poly 
(rA)(dT)n was found to be dependent on the length of the primer; short primer 
binding had a lower affinity.
Processivity and pausing of HIV-1 RT DNA synthesis
The processivity of a polymerase is defined as the number of nucleotides 
polymerized during a single binding event or cycle and describes the competition 
between elongation in the bound state and dissociation from template-primer 
(75). When DNA polymerases conduct one cycle of synthesis (processive DNA 
synthesis), the template position for termination of DNA synthesis (pausing) is 
non-random on heteropolymeric templates (76). Pausing occurs preferentially at 
certain nucleotide positions and termination probabilities vary at different 
template positions (77). HIV-1 RT has to polymerize approximately 20,000 
nucleotides to complete the conversion of single-stranded RNA genome into 
double-stranded proviral DNA (78). Following infection by HIV in culture, 
synthesis of the proviral DNA is completed within 4 to 8 hours (79, 80). Thus, 
HIV-1 RT polymerizes DNA at an average rate of about 1 nucleotide per second 
in vivo. In vitro, the processivity of HIV-1 RT ranges from about 1 nucleotide on 
poly dA to about 300 nucleotides on poly rA and on some M13 templates (67, 
81). HIV-1 RT processivity is relatively low compared to the other replicative
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polymerases and is observed to be strongly influenced by the template 
sequences (82). Studies of the structure of HIV-1 RT and its relationship with the 
processivity and pausing during DNA synthesis are important for understanding 
viral replication in vivQ. These studies should include the evaluation of the ability 
of template sequence to influence termination of DNA synthesis by HIV-1 RT.
Contribution of RNase H domain of p66 to processivity of DNA synthesis by 
HIV-1 RT
As described previously, the RNase H domain of HIV-1 RT resides in the 
carboxyl-terminal part of the protein. HIV-1 RT RNase H function has been 
identified as involving endo- as well as exonuclease activity (63). The carboxyl 
terminal region of HIV-1 RT has been recovered from an enzyme preparation 
from virus particles as an indepedent p i5 protein, and a combination of 
recombinant p15 and p51 leads to reconstitution of RNase H activity (83, 84). 
The coordination between RNase H activity and RNA-dependent DNA synthesis 
has been investigated. Models in which there is a tight coupling between DNA 
polymerization and RNA hydrolysis have been proposed (64, 85-86). However, 
evidence that RNase H function is less active than the polymerase function 
during processive DNA synthesis supports the uncoupled model (87, 88). 
Defects in RNase H function were found to disturb DNA polymerase activity of 
HIV-1 RT. AGIn475Glu mutant of HIV-1 RT, which has partially impaired RNase 
H activity, failed to hydrolyze homopolymeric substrates and showed a reduced 
processivity of the RNA dependent DNA polymerase (89). Two mutants of HIV-1 
RT, Asp443Asn and Asp443Asn/Asp498Asn lost detectable RNase H activity but 
appeared to retain wild-type activity of DNA synthesis on homopolymeric RNA 
templates (90). However, on heteropolymeric RNA templates derived from the 
gag region of HIV-1, these mutants could poorly extend the terminated nascent
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primer. It has been suggested that a catalytically functional RNase H domain is 
required to facilitate the reinitiation of DNA synthesis at specific pause sites along 
a heteropolymeric template (90). This suggestion is supported by the observation 
that the inability of the RNase H negative mutant to hydrolyze the RNA template 
blocked further DNA synthesis (91). It has also been suggested that 
conformation alteration induced by mutations in the RNase H domain can affect 
the favorable primer-template binding required for processive DNA synthesis 
(91). Bavand et al. have studied the polymerization properties of the p51 
homodimer. They concluded that the principal effect of the RNase H domain on 
polymerase function is that it contributes to the stabilization of the p51 subunit 
conformation in the heterodimer which is necessary for formation of the Michaelis 
complex (92).
Contribution of P51 to HIV-1 RT activity
Sequence alignments of RTs and other polymerases have suggested that 
the p66 subunit of the HIV-1 RT contains all the sequence information needed for 
activity (48). Also, it has been shown that the p66 chain provides the polymerase 
active site in the p66/p51 heterodimer (41,49). The monomeric forms of the HIV- 
1 RT, p66 and p51, have been shown to be enzymatically inert (93). Dissociation 
of either heterodimeric (p66/p51) or homodimeric (p66/p66 and p51/p51) 
recombinant HIV-1 RT leads to loss of RNA-dependent DNA polymerase activity 
in the resulting monomer, and it was reported that homologous HIV-1 RT 
subunits can rapidly associate to form active heterodimer (94). Hence 
monomeric p66, although it contains all the sequence information needed for 
activity, requires the interaction with a second polypeptide to maintain the 
favorable conformation for enzyme activity.
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In the crystal structure of HIV-1 RT, the folding of the p51 polypeptide was 
found to be astonishingly different from that of p66 (50). Unlike p66, p51 has no 
cleft for the primer-template binding, and the residues involved in catalysis are 
essentially buried. The two subunits interact in a manner such that the tip of the 
fingers and the connection subdomains of p51 interact with the palm and 
connection subdomains of p66 while the very extended thumb of p51 contacts 
the RNase H domain of p66. It is conceivable that the p66 monomer by itself 
would adopt a conformation similar to p51 and that this conformation might lack 
the physical cleft for primer-template binding. However, the protein-protein 
interactions of p66 with p51 (or p66 in homodimer) enables p66 to induce an 
enzymatically active conformation.
Effect of primer length on affinity for substrate
It has been shown that the Kd for poly(rA)(dT)n is dependent on the length of 
the primer, with short primers binding with a lower affinity (74). Short oligo (dT) 
primers (less than 14 nucleotides), annealed to poly(rA), bound RT relatively 
weakly (Kd = 20 - 30 nM), whereas oligo (dT) primers of 16 and 20 nucleotides in 
length bound tightly to RT (Kd -  0.1 nM) (74). The weak affinity is thought to be 
due to the fact that the dissociation of the RT-template-primer complex is much 
more rapid when the primer is short (74). Since, from the computer substrate 
binding model, the RNA-DNA duplex needs to contact both DNA polymerase and 
RNase H active sites and fit into a groove mainly folded by the p66 subunit, the 
short primer might cause insufficient interaction with the substrate binding groove 
and consequently make the primer-template easier to dissociate from RT than 
the substrate with long primer.
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Significance of this investigation
The modeling of the binding of an RNA/DNA strand into the cleft shown in 
the crystal structure (50) suggested that significant contacts between the RNase 
H domain and the primer-template are occurring. As described before, point 
mutations in the RNase H domain can impair the RNase H function and hinder 
DNA synthesis as well (89-91). It is important to investigate the correlation 
between primer-template binding and DNA synthesis of the RNase H negative 
enzyme.
In order to study the structure and function relationships of different forms of 
HIV-1 RT, a well characterized recombinant C-terminal deletion mutant of HIV-1 
RT will be employed. This mutant enzyme of HIV-1 RT has been cloned and 
expressed in S. cerevis iae  (35,95). A brief description of the genetic 
manipulation of this mutant clone as well as the p66 and p51 is given in Figure 6. 
A DNA fragment from restriction digestion at sites Bal-1 (Trp179) and Kpn-1 
(Trp690) of the HIV p o l open reading frame was fused with synthetic 
oligonucleotide adapters for desired coding regions. The N-terminus is expanded 
to Pro156 and the C-terminus to Ala693, Leu715, and Phe595 to construct three 
clones: p64, p66, and p51 respectively. The RT gene is flanked by promoter and 
terminator sequences of the yeast giyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) gene and inserted into pAB24, an autonomously replicating yeast 
plasmid containing LEU2 and URA3 markers for selection. The purified 
polypeptide, p64, which is missing of 22 amino acid residues in the RNase H 
domain of p66, lacks RNase H activity but retains the DNA polymerase activity 
(35, 95, 96). Heard et al. have demonstrated that p64 has the standard ordered 
Bi-Bi- mechanism as shown in wild-type enzyme with less affinity for the primer- 
template (97).
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Figure 6 Schematic relationship of HIV-1 RT clones (35,95).




















BamHl i Nco-1 Sal-1 , BamHl







P66 | , I I 560 residues
P51 I 1 I 440 residues
P64 i i i 1 538 residues
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
22
In this investigation, the specific aims are as follows:
1. Reconstitution of the different forms of HIV-1 RT.
P66, p51, and p64 (the C-terminal deletion mutant) will be used to generate 
wildtype (p66/p51) heterodimer, p66/p66 homodimer, p64/p64 homodimer, and 
p64/p51 heterodimer by a reconstitution method. The interactions of p66 or p64 
with p51 as heterodimers (p66/p51 and p64/p51) will be examined. The increase 
in DNA polymerase activity in both wildtype and mutant heterodimers of HIV-1 
RT relative to the homodimers will be expected if the catalytic subunits are 
interacting with p51 such that a favorable structure for DNA synthesis is adopted.
2. Investigation of the function of the C-terminal region in p66 on primer-template 
binding.
The dissociation constant for primer-template will be studied among these 
four forms of HIV-1 RT. p66/p66 is the form of HIV-1 RT whose small subunit 
contains an extra stretch of RNase H domain (p15) instead of p51 only as in the 
wildtype. The extra p15 might cause p66, the catalytic subunit, to adopt a 
conformation which affects primer-template binding. Also, the extra p15 might 
have a physical contact with primer-template and hence influence the primer- 
template binding. By comparing homodimers with p66/p51 heterodimers, the 
effect of this extra p15 on primer-template binding will be examined. P64/p5l is 
the form of HIV-1 RT which has 22 amino acid residues deleted at the C-terminus 
of p66. The truncated RNase H domain might cause the loss of the affinity for 
primer-template. This dissociation constant for primer-template of this mutant 
heterodimer will be compared to that of wild-type enzyme. p64/p64 is the form of 
HIV-1 RT which has not only an extra stretch of polypeptide on the small subunit, 
but also a 22 amino acid residue deletion in the RNase H domain of p66. The 
effect of these double defects on the primer-template binding will be examined.
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3. Investigation o f the function of C-terminal region in p66 on processivity.
The processivity of RNA-dependent DNA synthesis will be compared among 
these different forms of HIV-1 RT. The extra stretch of polypeptide in p66/p66 
might have altered the conformation of the catalytic subunit and hence influence 
the processivity of the enzyme. In p64/p51, the structure of the small subunit is 
as that in the wild-type, but the deletion in the catalytic subunit causes a defect in 
RNase H function. p64/p51 is not able to hydrolyze the RNA on the RNA-DNA 
duplex and hence might create blocks for DNA synthesis and hinder processivity. 
In p64/p64, the catalytic subunit assumes an altered conformation due to the 
interaction with p64 and lacks RNase H function. The processivity of this mutant 
enzyme will be compared to those in wild-type enzyme and p64/p51. Besides 
using poly(rA)(dT) as the primer-template for this investigation, a random base 
RNA template is synthesized to serve as a template for DNA synthesis by HIV-1 
RT. The significance of this template is that it is a natural substrate as that in 
vivo and, since the sequence of this template is known, the relationship between 
the primer extension pattern and the template sequence can be investigated.
4. Investigation o f the function o f the C-terminal deletion in p66 on primer- 
extension pattern.
The relationship between the processivity of DNA synthesis by HIV-1 RT 
and RNA template sequence will be investigated. The synthesized RNA 
template is 335 bases long and has a random sequence of ribonucleotides. By 
hybridizing the RNA template with a DNA 20-mer, 78 nucleotides can be 
incorporated to the 3' end of the primer. The primer extension pattern by 
p66/p66, p66/p51, p64/p64 and p64/p51 will be examined. The template 
sequence where DNA synthesis pauses will be compared.
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5. Investigation of the effect of primer length on the primer-template binding to 
p64/p51 mutant heterodimer
As described before, Beard et al. have reported that the Kd for poly(rA)(dT)n 
is dependent on the length of the primer with lower affinity for the short primer 
(74). The primer-template binding of p64/p51 will be characterized for its 
dependence on the primer length. A DNA 12-mer will be annealed to the 
RNA335 template. The Kd for RNA335-DNA12 and RNA335-DNA20 will be 
compared to investigate if the C-terminal deletion mutant shows lower affinity for 
the primer-template with shorter primer as in the wild type.
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II. Materials and Methods
Materials
Adenine. T y r o s i n e .  L v s i n e .  U r i d i n e .  Phenylalanine. Tryptophan. 
Methionine. Arginine, and Histidine: Purchased from Sigama.
AMV-RT (8.000 U/ml): Purchased from Promega.
Bacto- agar: Purchased from DIFCO.
P-mercaptoethanol: Purchased from BioRad.
BSA: Purchased from Promega as nuclease free stock solution at 10 mg/ml. 
Coomasie plus protein assay reagent: Purchased from Pierce.




and 2l-Deoxvcvtidine-5l-TriPhosphate fdCTPI 
: Purchased from Sigma and prepared as a 100 mM stock solution . 
Dithiothreitol (DTT): Purchased from Fisher are prepared as a 1.0 M stock 
solution.
DNA 5'-End Labeling System: Purchased from Promega.
fgamma-32P] Adenosine-S'-Triphosphate: Purchased from ICN Biomedicals,
INC., 10 mCi/ml, 2.2 pM.
Gel filtration standards: Purchased from BioRad.
GF/C glass microfibre filters: Purchased from Fisher.
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Guanosine-5'-diphosphate: Purchased from Boehringer Mannheim.
Guanyl (3'-5‘) uridine: Purchased from Sigma.
KCI: Purchased from Fisher and prepared as a 4 M stock solution.
LB broth: Purchased from DIFCO.
[Methyl.I'^'.^Hl-Thymidine-S'-triphosphate (pHydTTP): Purchased from 
Amersham,1.0 mCi, 8pM, 1.0 mCi/ml.
MgClfr Purchased from Fisher and prepared as 1 1.0 M stock solution.
NucTrap Push Columns: Purchased from Stratagene.
Oligomers ( 5 ’ GCT GGC GAA GGG GGG ATG TG 3'. 5' CTG GOA CGA CAG 
GTT TCC CG 3‘ for PCR. 5‘ GGT CCA CGG TAT CGA TAA GC 3' for RT
assays): Purchased from The Midland Certified Reagent Company.
Peptone: Purchased from Sigma.
Pfu: Purchased from Stratagene.
Phenol (Molecular Biology Grade): Purchased from Fisher. 
Phenylmethylsulfonyl fluoride (PMSF): Purchased from Sigma. 
Polynucleotide phosphorylase: Purchased from United States Biochemical, 3.2 
U/mg.
Polyriboadenosine-S'-monophosphate-Oligothmidine-S'monophosphate 
P0ly(rA)(<jT)j2 -1&: Purchased from Pharmacia,S2o.w for po iy(rA )= 5.8, poly(rA) to 
jd T li2- i8 was 1:1.
Pvu II: Purchased from Promega.
Ribomax Large Scale RNA Production System -T7: Purchased from Promega. 
RNA molecular weight marker: Purchased from Boehringer Mannheim 
Biochemica.
Sodium Pyrophosphate: Purchased from Fisher
S&S membrane filters: Purchased from Schleicher & Schuell, pore size : 0.45 
pm, s ize : 24 MM.
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Standard dialysis tubing (MWCO = 14.000): Purchased from Fisher.
Sterile filter: Purchased from Nalgene.
Superose 12 column: Purchased from Pharmacia.
100%Trichloroacetic acid (TCA): Purchased from Fisher in 500 g lots. Stock 
solution was prepared by the addition of 227 ml of MilliQ water to the bottle.
Tris Base: Purchased from Fisher and prepared as a 1 M stock solution at 
desired PH.
Triton X-100: Purchased from Fisher 
Tryptone: Purchased from DIFCO.
TSK-Gel G3000SW column: Purchased from TosoHaas.
Ultrafiltration membrane: Purchased from Amicon.
Uridine-5'-diphosphate: Purchased from United States Biochemical.
Yeast extract: Purchased from DIFCO.
Yeast Nitrogen base w/o Amino Acids: Purchased from DIFCO.
Methods
Preparation of Leu M  supplement
The Leu (-) supplement was prepared by combining 0.8 g of 
Adenine, 0.6 g of Tyrosine, 0.6 g of Lysine, 0.6 g of uridine, 1 g of Phenylalanine,
0.4 g of Tryptophan, 0.4 g of Methionine, 0.4 g of Arginine, and 0.4 g of Histidine.
Preparation of Leu M  rich media
The Leu (-) rich media was prepared by combining 10 ml of 10X yeast 
nitrogen base w/o amino acids (prepared by dissolving 6.7 g of nitrogen base in 
100 ml of MilliQ water), 0.5 g of Leu (-) amino acid supplement, 5 ml of 1%
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Tryptophan, 25 ml of 0.2% Adenine, 400 ml of 20% glucose, and 8 ml of 5% 
Threonine. The total volume was brought up to 1 liter with MilliQ water. The 
solution was sterilized by filtering through sterilizing membrane.
Preparation of YEP media
The YEP media was prepared by combining 20 g of peptone, 10 g of yeast 
extract, and 920 ml of MilliQ water and autoclaving the solution. 25 ml of 0.2% 
Adenine, 5 ml of 1% Tryptophan and 50 ml of 20% glucose were then added to 
the solution.
Yeast cell culture
The yeast cell culture was prepared by inoculating 20 ml Leu(-) rich media 
with 2 ml of yeast cells in a 250 ml bottle and shaking the culture at 30°C for 24 
hours. The culture was transferred to a 1 liter bottle containing 100 ml of Leu (-) 
rich media and shaken at 30°C for 24 hours. The culture was further transferred 
to a 2 liter flask containing 1 liter of YEP media and shaken at 30°C for 30-36 
hours. The yeast cells were then pelleted by centrifugation at 10,000 rpm in JA- 
14 rotor at 4°C for 20 minutes. The cell pellets were stored at - 70°C.
Preparation of veast cell Ivsis buffer
The yeast cell lysis buffer was prepared by combining the following 
quantities of stock solutions : 100 ml of 10X RT buffer (500 mM Tris, pH 7.8 , 2 
mM EDTA, 1% Triton X-100, and 500 M KCI), 700 ml of MilliQ water, 200 ml of 
glycerol, 3.7 g of KCI, 1.41 g of EDTA, and 154 pi of p-mercaptoethanol. The final 
solution contains 50 mM Tris, pH 7.8, 0.1% Triton X-100, 100 mM KCI, 20% 
glycerol, 4 mM EDTA, and 10 mM P-mercaptoethanol.
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Protein purification
The cloning of HIV-1 RT: pAB24/RT5 (p66), pAB24/RT6 (p51), and 
pAB24/RT4 (p64), in yeast has been described previously (Figure 6). The pellets 
from yeast cell culture were used for RT purification. Yeast cell pellets (from 1 
liter yeast cell cultures) were broken by glass bead lysis in 200 ml of lysis buffer 
in the presence of 1 mM PMSF. The lysis mixture was centrifuged at 10,000 
rpm, 0°C for 30 minutes. The supernatant was transferred to a cold beaker and 
(NH4)2S 0 4 (39.8 g per 100 ml of the supernatant) was added to salt out the 
proteins. The mixture was pelleted by centrifugation at 10,000 rpm, 0°C for 30 
minutes. The muddy pellets were then transferred into a dialysis tubing (MWCO = 
14,000) and dialyzed in 4 liters of 1X RT buffer (50 mM Tris, pH 7.8, 0.2 mM 
EDTA, 0.1% Triton X-100, 50 mM KCI, 10% glycerol, 10 mM (3-mercaptoethanol) 
overnight. The desalted mixture was then applied to a Whatman P11 
phosphocellulose column equilibrated in 1X RT buffer and eluted with a linear 50- 
800 mM KCI gradient. Fractions containing RT were determined by SDS-PAGE 
(10%), protein assay, and activity assay, and these fractions were pooled. 
Pooled fractions were concentrated and desalted in an Amicon pressure cell with 
a YM30 membrane (Amicon, MWCO = 30,000 MW) under 50 psi at 4°C. The 
concentrated fractions were then applied to an Affi-Blue column equilibrated in 
1X RT buffer without KCI. The column was washed with one bed volume of RT 
buffer (no KCI). Proteins were eluted with a linear 50-600 mM KCI gradient. 
Active fractions were pooled and concentrated as before. If necessary, RT was 
further purified by gel filtration on a Superose 12 column (Pharmacia). The 
elution buffer contains 100 mM Tris, pH 8.5, 10 mM p-mercaptoethanol, 1 mM 
EDTA, 0.1% Triton X-100, 50 mM KCI, and 10% glycerol. The purified protein 
was concentrated to 1-2 pg/pl, divided into 50 pi aliquots and stored frozen at 
-70°C. The purified enzyme was analyzed on SDS-PAGE as shown in Figure 7.
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Figure 7 SDS-PAGE analysis of p66, p64, p51, p66/p51, and p64/p51.1 pg of
each RT homodimer and 2 pg of each RT heterodimer were analyzed on an SDS 
polyacrylamide gel (10%) stained with Coomassie blue. Molecular weight 
standards shown on the gel are 97.4, 66.2, 42.7, 31,21.5, and 14.4 KD.
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Also, the relationship between the amount of dTMPs incorporated into 
poly(rA)(dT) template-primer and enzyme concentration was shown in Figures 8 
and 9 for p66/p66 and p64/p64 respectively to determine the optimal RT dilution 
for further studies.
Protein assay
The protein assay used for determining the protein concentration during the 
RT purification is based on the Bradford method which utilize an absorbance shift 
in an acidic Coomassie Brilliant Blue G-250 solution. An absorbance shift from 
465 to 595 nM occurs when Coomassie Blue G-250 binds to proteins in an acidic 
solution. The color response is relatively linear to the protein concentration. 0-10 
|ig/ml of BSA was used to obtain the linear relationship between the absorbance 
at 595 nM and protein concentration. The concentration of RT sample was 
obtained by the absorbance and the linear equation of the standard curve.
Preparation of LB (Luria - Bertainil medium
The LB medium contains 10 g of Bacto-tryptone, 5 g of Bacto-yeast, and 10 
g of NaCI in a water solution with final volume of 1 liter. The medium was 
autoclaved. Ampicillin was added to 100 pig/ml after autoclaved solution was 
cooled to 50°C.
Preparation of LB piate
15 g of agar was added to 1 liter of LB medium and autoclaved. Ampicillin 
was added to 100 pg/ml when the solution was cooled to 55°C for LB-Amp plate.
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Figure 8 dTMP incorporation by purified p66. Poly(rA)(dT)12- i8 was used as 
the template-primer and different dilutions of purified p66 were used in the 
assays.
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Figure 9 dTMP incorporation by purified p64. Poly(rA)(dT)i2- i8 was used as 
the template-primer and different dilutions of the purified p64 were used in the 
assays.
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30-35 ml of medium was poured into each 100 mm petri dish. After the plates 
hardened, they were stored at 4 °C .
Preparation of HB101 competent cells
1 ml of bacteria HB101 was inoculated into 10 ml of LB medium and 
incubated overnight at 37°C in a shaking chamber. The culture was streaked on 
an LB plate and incubated overnight at 37°C. One bacterial colony from the LB 
plate was inoculated into 5 ml LB medium and incubated overnight at 37°C in a 
shaking chamber. 1 ml of the bacterial culture was used to inoculate 100 ml of 
LB incubated at 37°C in a shaking chamber for 2-4 hours until OD550 = 0.5. 50 
ml of the culture was put into each of two sterile centrifuge tubes, and they were 
chilled on ice for 10 minutes. The cells were pelleted by centrifugation at 4,000 x 
g (7,000 rpm) at 4°C for 5 minutes. They were resuspended in 25 ml of ice-cold, 
sterile trituration buffer (50 mM CaC^and 10 mM Tris, pH 8.0). Placed in an ice 
bath for 15 minutes, and centrifuged as before. The supernatant was decanted 
and cells resuspended in 3.3 ml of trituration buffer. The final suspension of cells 
was stored at-70°C.
Transformation of HB101 with plasmid Bluescript KS(+)
A 200 pi aliquot of HB101 competent cells was thawed on ice and 1-6 pi of 
plasmid (40 ng/ml) was added. Cells were left on ice for 30 minutes and then 
heat shocked at 42°C for 2 minutes. 1 ml of LB was added to each tube and the 
mixtures were incubated at 37°C for 1 hour without shaking. 50 pi of the culture 
was spread on LB-Amp plate and incubated at 37°C for 16-24 hours.
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Isolation of plasmid DNA from HB1 01/p BS
A 2.5 ml overnight culture from a single colony was used to inoculate a 2- 
liter flask containing 500 ml of LB-Amp medium. The 500 ml culture was 
incubated 12-16 hours at 37°C with shaking. The bacterial cells were harvested 
by centrifugation at 4000 x g (10,000 rpm) at 4°C for 20 minutes. The pellet was 
recovered and stored at -70°C if not used immediately. The pellet from the 500 
ml culture was resuspended in 5 ml of solution I (50 mM glucose, 10 mM EDTA, 
and 25 mM TrisCI, pH 8.0). After 10 minutes at room temperature, 10 ml of fresh 
solution II (0.2 N NaOH and 1% SDS) was added. The suspension was stirred 
and allowed to sit on ice for 10 minutes. 7.5 ml of solution III (3 M potassium 
acetate and 11.5% glacial acetic acid) was added, mixed, and the solution was 
chilled for another 10 minutes on ice. After centrifugation at 20,000 x g (13,000 
rpm, JA20) at 4°C for 10 minutes, the supernatant was transferred to a fresh 
tube, 0.6 volumes of isopropanol was added, and the sample was centrifuged 
again at 15,000 x g (11,500 rpm, JA20). The pellet was washed with 2 volumes 
of 70% ethanol and dried under vacuum. After resuspension in 4 ml of TE (10 
mM TrisCI, pH 7.6, 1 mM EDTA), 4.4 g of CsCI and 0.4 ml of 10 mg/ml Ethidium 
Bromide were added. The mixture was centrifuged at 350,000 x g (58,000 rpm, 
VTi 65) for 20 hours. The lower band was collected by a needle and syringe, and 
the Ethidium Bromide was removed by repeated extraction with isopropyl alcohol. 
The CsCI was removed by dialysis in TE buffer.
Preparation of 10X RT assay buffer
The 10X RT assay buffer was prepared by combining the following 
quantities of stock solutions: 1250 pi of 1 M Tris (pH 8.5), 145 pi of 1 M MgC^, 
500 pi of 4.0 M KCI, 200 pi of 1M DTT, 125 pi of 10% Triton X-100, and 280 pi of
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MilliQ water. The final volume was 2500 pi. The buffer contains 500 mM Tris, 
60 mM MgCl2, 800 mM KCI, 80 mM DTT, and 0.5% Triton X-100.
Preparation of polv(rAKd'n1?.1a stock solution
The lyophilized poly(rA)(dT)12-i8 (25 units) was dissolved by adding 15 pi of 
4 M KCI and 781 pi of (10 mM Tris/ 1mM EDTA) to the bottle to make a final 
concentration of 2.0 pg/ul. The molarity of the poly(rA)(dT)i2-is was obtained 
from the following equation (119): Log(M) = 2.179 (Log (S20.W ) + 1.523). A 
molecular weight of 95968 g/mole was obtained from the S 2o,w of 5.8 in the 
certificate of analysis. The average base length corresponding to this 
sedimentation constant is 258 polymerized adenosine-5-monophosphate bases. 
Final stock concentration of the poiy(rA)(dT)12-i8 was 20.8 pM.
RT activity assay
The RT activity assays were carried out in a 50 pi mixture containing 50 mM 
Tris (pH 8.5), 0.05% Triton X-100,10 mM MgCI2, 60 mM KCI, 8 mM DTT, 0.05% 
Triton X-100, 6 mM MgCI2, 80 mM KCI, 2 pg of poiy(rA)(dT), 80 pM dTTP, and 
0.25 mCi/nmol [3H]-dTTP. Reactions were initiated by the addition of 10 pi of 
diluted enzyme to 40 pi of cocktail solution and incubated at 37°C for 30 minutes. 
The reactions were quenched with 800 pi of ice cold 10% TCA containing 10 mM 
PPi and maintained at 0°C until precipitated material was collected on Whatman 
GF/C filters. Each filter was washed with 8 ml of the cold TCA solution and then 
rinsed with 1-2 ml ethanol. The dry filters were counted in a 5 ml CytoScint 
scintillation cocktail in a Scintillation Counter. Activity of RT is indicated by the 
amount of [3H]-dTTP incorporation in 30 minutes at 37°C.
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Nitrocellulose Binding Assays
The labeled primer-template was first prepared by using AMV-1 RT to 
incorporate [3H]-dTTP onto poly(rA)(dT). The labeled primer-template was 
incubated with RT (0-10 nM) with RTB in a final volume of 800 pi for 15 minutes 
at 0°C. The mixture was filtered through nitrocellulose filters to capture the 
enzyme bound primer-template. The filters were placed in vials containing 5 ml 
of scintillation cocktail and counted on a Beckman liquid scintillation counter. The 
Kd was calculated by the Eadie plot method.
Polv(U.G) synthesis
Polynucleotide phosphorylase (0.5 units/ml) was incubated overnight at 
37°C in a reaction mixture containing 0.15 M Tris, pH 9.0, 1 mM EDTA, 0.5mM 
Guanyl (3'-5‘) uridine, 1mM MgCl2, 2 mM GDP, 2mM UDP, and 1 ml of water. 
The poly(U,G) mixture was extracted with phenol and chloroform and 
resuspended in 100 pi of TE buffer after ethanol precipitation. Concentration was 
determined by optical density at 260 nM. Analysis of 5 pg of the sample by 
agarose gel electrophoresis showed the average size to be 0.5 kb.
Processivity assays on polvfrAKdTI
Assays to determine the processivity of RTs were carried out by using 
poly(U,G) as challengers. RT was incubated with poly(rA)(dT) (40 ng/pl) at 0°C 
for 10 minutes and the reaction was initiated by adding MgCl2 (6mM), [3H]-dTTP 
(80 pM, 0.25 mCi/nmol), and poly(U,G) (0.1-0.2 mg/ml). The mixture was 
incubated at 37°C and aliquots of 50 pi were removed at times over a 30 minutes 
interval for counting to obtain the curve of time course incorporation. Assays 
without poly(U,G) were also carried out for the control curve. The time required
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
38
for one processive cycle was estimated from the point where the control and 
poly(U.G) curves separate.
Enzvme Reconstitution
Reconstituted heterodimers, p66/p51 and p64/p51, were made by 
incubating the corresponding enzyme preparations (p66 + p51 and p64 + p51) at 
1:1 by weight in a buffer containing 100 mM Tris, pH 8.5, 10 mM p- 
mercaptoethanol, 1 mM EDTA, 0.1% Triton X-100, 50 mM KCI, and 10% glycerol 
at 4°C for more than 24 hours. The effect of reconstitution was determined by 
comparing the activity of incorporating dTMPs onto primer-template. Each 
activity assay has a volume of 20 pi and contains dNTPs (50 pM), 1 pg of 
poly(rA)(dT) or RNA335-DNA20 (0.5 pM), 0.5 pCi of [3H]-dTTP, and RT (0-25ng).
Polymerase Chain Reaction
Plasmid Bluescript (+) (the sequence is shown in Appendix 1) was used as 
a template in a polymerase chain reaction to amplify a 446 bp fragment that 
contains the T7 promoter sequence. Two primers have the sequences of 5' 
GCTGG CGAAG GGGGG ATGTG3' and 5'CTGGC ACGAC AGGTT TCCCG 3'. 
A 100 pi PCR reaction mixture is comprised of 24 pi of water, 10 pi of 10X PCR 
buffer, 6 pi of 500 pM dNTPs, 2 pi of each 50 pM primer and 1 pi of 278 ng/pl 
pBluescript. The 10X PCR buffer contains 60 mM Tris, pH 7.5, 500 mM NaCI, 60 
mM MgCb, and 10 mM DTT. The mixture was initiated by heating at 95°C for 
10 minutes followed by 30 amplification cycles of denaturing (95°C for 5 
minutes), annealing (68°C for 5 minutes) and DNA synthesis (75°C for 5 minutes) 
steps. The 446 bp DNA mixture was extracted with phenol and chloroform and 
resuspended in 20 pi of TE buffer after ethanol precipitation. Concentration was
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determined by optical density at 260 nM. Analysis of 5 pg of the sample by 
agarose gel electrophoresis showed the size to be 0.45 kb.
Run-off Transcription
A run-off transcription on the 446 bp PCR product was carried out by using 
T7 RNA polymerase. The reaction has a total volume of 20 pi and contains 4 pi 
of 5X transcription buffer, 2.4 pi of 25 mM rNTPs, 2 pi of 0.6 pg/pl DNA template, 
10.6 pi of water and 1 pi of 35U/pl T7 RNA polymerase purchased from 
Promega. The transcription 5X buffer contains 400 mM HEPES-KOH, pH 7.5, 60 
mM MgCI2, 10 mM spermidine and 200 mM DTT. The mixture was incubated at 
37°C for 4-6 hours. A 335 nucleotide RNA was expected from the reaction. The 
reaction mixture was first run through a push column to remove unincorporated 
mononucleotides and then extracted with phenol and chloroform and 
resuspended in 20 pi of DEPC-treated water after ethanol precipitation. 
Concentration was determined by optical density at 260 nM. Analysis of 2 pg of 
the sample by denaturing agarose gel electrophoresis showed the RNA band to 
fall between the markers of 0.3 and 0.4 kb. The RNA sample was stored at 
-70°C. The sequence of the RNA produced is shown in Appendix 2. Also, a line 
diagram and the procedure of generation of this template-primer is shown in 
Figure 10. The linear relationship between log (kb) and distance migrated is Log 
(kb) = -0.411 x distance+ 0.719 as shown in Figure 11. The RNA sample has a 
distance migrated of 2.9 cm and its corresponding size calculated from the linear 
equation is 0.33659 kb.
5' end labeling of primer
The primers for primer extension reaction were 5' end labeled by [y-32P]- 
ATP. In a 10 pi reaction, 10 pmol of primer, 30 pCi of [y-32P]-ATP and 8 U of T4
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Figure 10 A schematic representation of the method used to generate 
random base template-primer.
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Figure 11 Plot of size of RNA markers (kb on log scale) against the distance 
migrated. The arrow indicates the location of the run-off transcription product.
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polynucleotide kinase were combined in a 1X buffer containing 50 mM Tris-CI, 
pH 9.0, 1 mM MgCb, 0.1 mM ZnCI2 and 1 mM spermidine. The mixture was 
incubated at 37°C for 60 minutes and stopped by adding 2 pi of 0.5 M EDTA 
and 50 pi of TE buffer and heating at 65°C for 5 minutes. The reaction mixture 
was then run through a push column to remove unincorporated mononucleotides.
Annealing
The RNA335-DNA20 template-primer was prepared by combining 7.5 pmol 
of DNA20 primer and 2.5 pg RNA335 template in 100 pi of the hybridization 
buffer containing 50 mM Tris, pH 8.0, 80 mM KCI and 1 mM EDTA. The mixture 
was incubated at 90°C for 3 minutes and shifted to 60°C to cool down to 25°C in 
60 minutes. The annealed RNA335-DNA20 mixture has a final concentration of 
75 nM.
Primer extension
Reaction of DNA synthesis on RNA335-DNA20 template-primer by RT was 
visualized by autoradiography on an 8 M urea, 10% polyacrylamide gel. The 
primer was 5' end labeled with [y-32P]-ATP before annealing to the template. 
Each primer extension reaction contains 10 nM RNA335-DNA20, 50 pM dNTPs 
and 0.1 pg/pl RT in 1X RT assay buffer. 7.5 pi of the reaction mixture was 
withdrawn and stopped by the addition of 3 pi of stop solution at 0, 5, 15, 30, 45, 
60, 90,120, 180 and 240 minutes.
Assays to determine Kh for random RNA template primer
The Kg for RNA335-DNA20 and RNA335-DNA12 was obtained by using 
poly(rA)(dT) as a challenger. 0.1 pg/pl RT enzyme and p2P]-labeled RNA335- 
DNA20 or RNA335-DNA12 (0 - 45 nM) were incubated on ice for 10 minutes to
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form an RT/template-primer complex. 0.2 pg/pl of poly(rA)(dT) and 50 pM 
dNTPs were used to initiate the DNA synthesis on RT/template-primer complex 
at 37°C for 30 minutes. In control reactions, poly(rA)(dT) was examined on its 
ability to trap free RT molecules by combining RT, template-primer, and 
poly(rA)(dT) at the same time before dNTPs were added to initiate the reaction. 
10 pi of each reaction mixture was analyzed on an 8 M urea 10% polyacrylamide 
gel. The amount of unbound template-primer was evaluated from the 
radioactivity of the unextended primer. The bands corresponding to the DNA 20- 
mer or DNA 12-mer were excised, mixed with 5 ml of scintillation fluid and 
counted. The amount of RT/template-primer complex was calculated by 
subtracting the amount of RNA335-DNA20 or RNA335-DNA12 used in the 
reaction by the amount of free template-primer. The Kd was calculated by using 
Eadie plot method.
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III. Results 
Reconstitution of d66/p51 and p64/p51
HIV-1 RTs, p66, p64, and p51, were expressed and purified from yeast £. 
cerevisiae that carries the corresponding gene (Figure 6). According to the 
previous studies on these three clones, the p66 molecules can associate as 
homodimers (35) and p66 and p51 were shown to associate as heterodimers 
(35). Also, it was demonstrated that p66/p66 retained approximately 80% of the 
RT activity of the heterodimers (35). The C-terminal deletion in the mutant, p64, 
was shown to abolish RNase H activity (96). But, the mutant retained wildtype 
DNA polymerase activity and an Ordered Bisubstrate mechanism of 
polymerization (97). As shown in Figure 6, p66 contains 560 residues: Pro1 to 
Leu560; p64 contains 538 residues: Pro1 to Ala538; and p51 contains 440 
residues: Pro1 to Phe440. In order to study the structure-function relationships of 
HIV-1 RT, these three clones of RT were reconstituted to the different forms of 
enzyme : p66/p66, p66/p51, p64/p64, and p64/p51. SDS-PAGE analysis of each 
individual clone and the reconstituted heterodimer is shown in Figure 7. The 
effect of heterodimer formation on RNA-dependent DNA polymerase activity was 
examined by using poly(rA)(dT)12.ia as template-primer. As shown in Figure 12 
and Figure 13, the amount of dTMP incorporated into poly(rA)(dT)12-1 s increases 
when the enzyme concentration in the reaction increases and the heterodimer is 
able to incorporate more dTMP into primer-template relative to homodimer when 
both are at the same concentration. These results indicate that reconstitution of
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Figure 12 Reconstitution of p66/p51 heterodimer increases RT activity. The
incorporation of dTMPs on a poly(rA)(dT) template-primer was compared 
between p66/p66 (■-■) and p66/p51 ( • - • )  by activity assays. Standard error for 
each point was less than 5%.
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Figure 13 Reconstitution of p64/p51 heterodimer increases RT activity. The
incorporation of dTMPs onto poly(rA)(dT) template-primer was compared 
between p64/p64 (■ •■ ) and p64/p51 ( • - • ) .
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p66 or p64 with p51 is able to increase the DNA polymerase activity on 
poly(rA)(dT)i2- i8- Also, since the RT activity increases when the corresponding 
subunits were mixed and incubated, subunit interaction in both heterodimer 
forms, p66/p51 and p64/p51, is stronger than that in either homodimer.
Processivity assays of RTs on poly(rA)(dT)
Processivity refers to the number of nucleotides a polymerase can add to 
the nascent chain during polymerization before the polymerase dissociates from 
the primer-template. Poly (U,G) was employed in the processivity assay as a 
template-primer challenger; an excess of poly (U,G) was added to the assay 
when the reactions were initiated. Since a preincubation with primer-template 
preceded reaction initiation, HIV RT has already formed initiation complexes with 
poly (rA)(dT) and incorporation of [3H]-dTMP will proceed while these complexes 
are intact. However, when the enzyme dissociates from the new chain on the 
original primer-template, the excess poly (U,G) "traps" the RT as it binds to a 
template without a primer or complementary nucleotides. Thus, reinitiation is 
prevented. The results of these processivity assays are shown in Figures 14-17. 
As seen in Figure 14, the level of dTMP incorporation by the p66/p66 homodimer 
continues to increase until approximately eight minutes, at which point the level 
of incorporation becomes constant in the reaction with challenger. However, the 
level of incorporation continues to increase normally in the unchallenged control 
reactions. These results indicate that the homodimer catalyzes nascent chain 
elongation on the same primer-template until it dissociates after eight minutes; 
then the free homodimer is trapped by poly (U,G) and unable to incorporate any 
more dTMP. Similarly, in assays investigating the processivity of the 
p66/p51 heterodimer, p64/p64 homodimer, and p64/p51 heterodimer (Figures 15 
- 17), incorporation increases up to fifteen minutes, four minutes, and eight
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Figure 14 Assays to determine the processivity of p66/p66 homodimer.
indicates the incorporation of dTMP for unchallenged enzyme assay, and 
indicates the incorporation of dTMP for enzyme assayed in the presence of 
poly(U,G). The standard deviation of each point is less than 5%.
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Figure 15 Assays to determine the processivity of p66/p51 heterodimer.
indicates the incorporation of dTMP for unchallenged enzyme assay, and 
indicates the incorporation of dTMP for enzyme assayed in the presence of 
poly(U.G). The standard deviation of each point is less than 5%.
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Figure 16 Assays to determine the processivity of p64/p64 homodimer.
0 - 0  indicates the incorporation of dTMP for unchallenged enzyme assay, and 
indicates the incorporation of dTMP for enzyme assayed in the presence of 
poly(U.G). The standard deviation of each point is less than 5%.
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Figure 17 Assays to determine the processivity of p64/p51 heterodimer.
indicates the incorporation of dTMP for unchallenged enzyme assay, and 
indicates the incorporation of dTMP for enzyme assayed in the presence of 
poly(U,G). The standard deviation of each point is less than 5%.
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minutes respectively. These observations indicate that the order of processivity 
of different forms of RT is : p66/p51 (15 min) > p66/p66, p64/p51 (8 min) > 
p64/p64 ( < 4 min). The heterodimer of each wild type and C-terminal deletion 
mutant was shown to be more processive than the corresponding homodimer.
Nitrocellulose Binding Assays to determine the for PolvfrAMcm
The differences in processivity observed among different forms of HIV-1 RT 
might be related to potentially different affinities of each enzyme form for the 
primer-template. So, the affinity of different forms of enzyme to poly(rA)(dT) was 
compared by binding assays. The K<j was calculated based on the Eadie 
method (100). The binding of RT enzyme (E) to primer-template (L) is decribed 
by the following equation:
E + L <--> EL 
Kd = [E][L]/[EL]
where [E] and [L] are the concentrations of the unbound enzyme and primer- 
template, and [EL] is the concentration of enzyme-ligand complex.
In terms of the total enzyme concentration [Efo,
[E] = [E]0 - [EL]
the equations
[E0] - [EL] = Kd [EL]/[L] and 
[EL] = [E0] -Kd [EL]/[L] 
can be obtained. By plotting [Eo] - [EL] versus [EL]/[L] or [EL] versus [EL]/[L], Kd 
can be evaluated form the slope of the curve. As shown in Figure 18, the Kd of 
wild type enzyme for poly(rA)(dT) was obtained by plotting [Eo] - [EL] versus 
[EL]/[L], Similarly, as shown in Figure 19, [EL] versus [EL]/[L] was plotted to 
obtain the Kd for the mutant enzyme. The resulting Kd for p66/p66, p66/p51, 
p64/p64, and p64/p51 are 16.9±0.1, 12.8±0.3, 392+4, and 21.6±0.3 nM
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Figure 18 Eadie plot of nitrocellulose filter binding assays to determine the 
affinity of p66/pp66 (▲•▲), p66/p51 ( • - • ) ,  and p51 ( l-K )  for poly(rA)(dT).
The standard deviation of each point is less than 5%.
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Figure 19 Eadie plot of nitrocellulose filter binding assays to determine the 
affinity of p64/pp64 ( • - • ) , and p64/p51 (♦-♦)for poly(rA)(dT). The standard 
deviation of each point is less than 5%.
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respectively. The relationship between processivity and affinity for poly(rA)(dT) 
primer-template is shown in Table 2. Each heterodimer, p66/p66 or p64/p64, has 
a higher affinity for the primer-template than its homodimer. These results 
suggest that the increase in processivity seen in the heterodimer is due to the 
p51 subunit.
Activity assays on RNA335-DNA20 bv the reconstituted enzvme
in. vivo. HIV-1 RT transcribes the viral RNA genome, which is a random 
base template (23). Relative to poly(rA), a random base RNA template forms 
complex secondary structures more easily. The wildtype HIV-1 RT has been 
shown to have different processivities on random base RNA templates from 
those on poly(rA) (67,81). Pausing can occur preferentially at certain nucleotide 
positions during DNA synthesis on a random base RNA template (77). In order 
to examine the relationship between RT structure and the DNA polymerase 
function on the random base templates, a 335 nucleotide RNA was generated 
from plasmid Bluescript by T7 RNA polymerase and used as the template for 
transcription by RT (Figures 10,11). A 20 nucleotide oligomer was annealed to 
this RNA template at a position such that 78 nucleotides could be added to the 
primer for full length transcription (Figure 10). The incorporation of dNMP was 
then compared between heterodimer and homodimer to investigate the 
contribution of the p51 subunit to the enzyme activity on this random base RNA 
template-primer. As shown in Figures 20 and 21, the results obtained were 
similar to those in which poly(rA)(dT) was the primer-template. The amount of 
dNMP incorporated into RNA335-DNA20 increases when the enzyme 
concentration in the reaction increases and the heterodimer is able to incorporate 
more dNMP into this primer-template relative to homodimer when both are at the
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Table 2 Processivity and Kd of HIV-1 RT for poly(rA)(dT).
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Enzyme p66 /p6 6  p66/p51 p64 /p64  p64 /p51
Processivity 8 ' 1 5 ' <4 * g '
Kd(nM ) 16.9±0.1 12.86±0.3 392±4 21 .6±0 .5
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Figure 20 Reconstitution of p66/p51 increases RT activity on RNA335- 
DNA20. The incorporation of dTMPs onto RNA335-DNA20 was compared 
between p66/p51 ( • - • )  and p66/p66 (■-■).
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Figure 21 Reconstitution of p64/p51 increases RT activity on RNA335- 
DNA20. The incorporation of dTMPs onto RNA335-DNA20 was compared 
between p64/p51 ( • - • )  and p64/p64 (■-■).
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same concentration. These results indicate that reconstitution of p66 or p64 with 
p51 is able to increase the DNA polymerase activity on RNA335*DNA20.
Primer extension on RNA335-DNA20 bv HIV-1 RT
It was observed that heterodimer is more processive than homodimer by 
using poly(rA)(dT) as the template-primer as described above. It is important to 
further investigate the processivity on the random base RNA template which is 
the natural substrate of HIV-1 RT. A random base RNA template can form 
secondary structure due to hydrogen bonds between bases. Also, the RNA 
sequence might carry information that will direct the polymerization by HIV-1 RT. 
The influence of enzyme structure on processivity on a random base RNA 
template could also be important. In these studies, since the primer was first 5' 
end labeled with [32P]-ATP before it was annealed to the template, the extension 
of the primer by RT can be visualized by autoradiography. The labeled RNA335- 
DNA20 was incubated with RT enzyme for different periods of time so that the 
effect of reaction time on extension pattern can be observed. DNA size markers 
were used to indicate the size of the extended primer. Also, by referring to the 
RNA template sequence, the sequences of pause sites were obtained. The 
primer extension patterns by homodimer and heterodimer of both wild type and 
mutant enzyme were compared. The elongation of nucleotides was visualized by 
an 8 M urea 10% polyacrylamide gel followed by exposure to the X ray film. The 
results (Figures 22-25) showed that the DNA products extended by p64/p64 
homodimer were mainly 38 nucleotides long with a small fraction of the products 
at 23 to 25 nucleotides long. Unlike p64/p64, however, p66/p66 extended the 
primer to mostly 38 nucleotides long. Mutant heterodimer, p64/p51, was able to 
further extend the primer to 62 nucleotides long with small pausing at 43 to 44 
nucleotides long. In comparison, the wildtype heterodimer was able to extend
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Figure 22 Primer extension by p64/p64 on RNA335-DNA20. Time course of 
RNA-dependent DNA synthesis on the random base template by RT is shown on 
an 8 M urea 10% polyacrylamide gel. Reactions were stopped at 0, 5,15, 30,45, 
60, 90, 120, 180, and 240 minutes as described under Materials and Methods 
(lanes 2 - 11). The primer (20-mer) alone (lane 1) was used to indicate the 
position of the unextended primer. Lanes 12 -1 4  are DNA size markers which 
indicate the position of 25, 31, 33, 34, 35, 44, and 61-mer and were used to 
determine the position of pause sites. . .
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Figure 23 Primer extension by p64/p51 on RNA335-DNA20. Time course of 
RNA-dependent DNA synthesis on the random base template by RT is shown on 
an 8 M urea 10% polyacrylamide gel. Reactions were stopped at 0, 5,15, 30, 45, 
60, 90, 120, 180, and 240 minutes as described under Materials and Methods 
(lanes 2 - 11). The primer (20-mer) alone (lane 1) was used to indicate the 
position of the unextended primer. Lanes 12 -1 4  are DNA size markers which 
indicate the position of 25, 31, 33, 34, 35, 44, and 61-mer and were used to 
determine the position of pause sites.
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Figure 24 Primer extension by p66/p66 on RNA335-DNA20. Time course of 
RNA-dependent DNA synthesis on the random base template by RT is shown on 
an 8 M urea 10% polyacrylamide gel. Reactions were stopped at 0, 5,15, 30, 45, 
60, 90, 120, 180, and 240 minutes as described under Materials and Methods 
(lanes 2 - 11). The primer (20-mer) alone (lane 1) was used to indicate the 
position of the unextended primer. Lanes 12 - 14 are DNA size markers which 
indicate the position of 25, 31, 33, 34, 35, 44, and 61-mer and were used to 
determine the position of pause sites.
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Figure 25 Primer extension by p66/p51 on RNA335-DNA20. Time course of 
RNA-dependent DNA synthesis on the random base template by RT is shown on 
an 8 M urea 10% polyacrylamide gel. Reactions were stopped at 0, 5,15, 30, 45, 
60, 90, 120, 180, and 240 minutes as described under Materials and Methods 
(lanes 2 - 1 1 ) .  The primer (20-mer) alone (lane 1) was used to indicate the 
position of the unextended primer. Lanes 12 - 14 are DNA size markers which 
indicate the position of 25, 31, 33, 34, 35, 44, and 61-mer and were used to 
determine the position of pause sites.




•  *  *  - *  — 44
f t i
—  35 
— 31
—  25 
— 20
< I  I  !  I  I  »  I I  f  O
Primer Extension of HT5* on RNI&35-20
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
64
the primer to 62, 65, and 74 nucleotides long and more. Little earlier pauses 
were detected for p66/p51 like those seen in p64/p51. These results indicate that 
heterodimer is more processive than homodimer on RNA335-DNA20 template- 
primer in both wildtype and mutant enzymes. Furthermore, the C-terminal 
deletion decreases the processivity of the enzyme.
Interaction of HIV-1 RTwith RNA335-DNA20
Since a correlation between processivity and the affinity of the enzyme for 
poly(rA)(dT) was observed, it is important to determine if the processivity is also 
correlated with the interaction between different RT forms and RNA335-DNA20. 
The amount of RNA335-DNA20 bound by RT is proportional to the amount of the 
primer that is extended when RT molecules can be trapped and prevented from 
binding to the substrate provided that the RT-substrate complex dissociates after 
a processive cycle of DNA synthesis. A diagram is shown in Figure 26 to depict 
the method for investigating the interaction between RT and RNA335-DNA20. 
RT was preincubated with [32 P]-labeled RNA335-DNA20 for 10 minutes on ice. 
Poly(rA)(dT) and dNTPs were added to the mixture to initiate the reaction. The 
presence of poly(rA)(dT) trapped the free RT molecules and hence prevented the 
RT molecules from reassociating with RNA335-DNA20. The ability of 
poly(rA)(dT) to trap free RT molecules was demonstrated by incubating the RT 
enzyme, RNA335-DNA20, and poly(rA)(dT) first before dNTPs were added to 
initiate the reaction. The DNA synthesis on RNA335-DNA20 in the presence of 
poly(rA)(dT) was poorly seen on the autoradiogram as compared to the primer 
extension results without the presence of poly(rA)(dT). These observation 
suggest that poly(rA)(dT) is capable of competing the binding of RNA335-DNA20 
to the RT molecules. In the binding assays, the bands corresponding to the 
primer were excised and counted for the amount of unbound RNA335-DNA20.
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Figure 26 Scheme to determine Kd for RNA335-DNA20.
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The amount of the bound RNA335-DNA20 was obtained by subtracting the total 
amount of RNA335-DNA20 used by the amount of the unbound RNA335-DNA20. 
The Eadie plot method was used as described before to obtain the K<j for 
RNA335-DNA20. The results showed that the K(js for RNA335-DNA20 were 
8.6+0.5, 7.1±0.5, 6.0±0.5, and 18.0±0.5 nM for p64/p64, p64/p51, p66/p66, and 
p66/p51 respectively as shown in Figure 27 -28. RNA335-DNA20 appeared to 
bind to p64/p64/, p66/p66, and p64/p51 even tighter than to p66/p51 according to 
the results, and the processivity on RNA335-DNA20 did not seem to have a 
significant correlation with the KdS obtained in these binding assays.
Effect of primer length on affinity for substrate
The affinity for RNA335-DNA12 was examined between wildtype and 
mutant heterodimers. The RNA-DNA duplex must fit into a primer-template 
binding groove in RT and contact both DNA polymerase and RNase H active 
sites. A short primer might cause insufficient interaction with the binding groove 
and hinder enzyme function. By using the same method described for 
determining the Kd for RNA335-DNA20, the Kd for RNA335-DNA12 is 27.7 and 
2.1 nM for p66/p51 and p64/p51 respectively as shown in Figure 29. The 
random base RNA template hybridized with a 12-mer was shown to have a 
weaker interaction with p66/p51 than that hybridized with a 20-mer. The mutant 
heterodimer has a Kdfor RNA335-DNA12 smaller than that for RNA335-DNA20. 
The random base RNA template-primer appeared to bind tightly to the non- 
wildtype enzyme as already observed.
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Figure 27 Eadie plot of binding assays to determine the affinity of p66/p66 
(■ -■) and p66/p51 ( • - • )  for RNA335-DNA20. The standard deviation of each 
point is less than 5%.
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Figure 28 Eadie plot of binding assays to determine the affinity of p64/p664 
(■-■) and p64/p51 (# -# )  for RNA335-DNA20. The standard deviation of each 
point is less than 5%.
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Figure 29 Eadie plot of binding assays to determine the affinity of p66/p51 
(■ -■) and p64/p51 ( • - • )  for RNA335-DNA12. The standard deviation of each 
point is less than 5%.
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Relationship between the template sequence and pause sites of primer 
extension
It has been observed that DNA template-directed polymerization by HIV-1 
RT is error-prone for single nucleotide substitution, addition and deletion errors in 
homopolymeric sequences (108). Also, it has been noted that strong termination 
of processive synthesis occurs at these hot spots (108). It is important to 
investigate the RNA template sequences, presumably the potential mutation hot 
spots, where the pauses of processive DNA synthesis tend to occur. As shown 
in Figures 22-25, DNA synthesis by RT was paused when the primer was 
extended to specific length. The sequences of the template where the primer 
extension paused were compared as shown in Figure 30. The template 
sequences that were related to the pause sites were found to be those rich in G 
and C bases. The progress of the DNA synthesis by HIV-1 RT was hence 
dependent on the template sequence. This observation was further confirmed by 
using two other primers which have the same 5' termini of the 20 nucleotide 
primer used in the primer extension reaction as showed below :
20-MER 5'GGTCG ACGGT ATCGA TAAGC
12-MER 5'GGTCG ACGGT AT
25-MER 5'GGTCG ACGGT ATCGA TAAGC TTGAT
These three primers were extended to a same pause site (38 nucleotide 
long) regardless of the length of the primers. Also, the ability to extend over the 
G C rich template was found various in different form of HIV-1 RT. The wild type 
heterodimer, p66/p51 was the enzyme most able to extend the primer over the G 
C rich regions. These results suggest that the processivity of HIV-1 RT on 
random base template depends on the template sequence. Certain template 
sequences are able to command RT to pause the DNA synthesis. Also, RT
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Figure 30 The sequence alignment of pause sites on random base template 
byRT.
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structure plays an important role in rebinding the primer-template and further 
extending the terminated primers.
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IV. Conclusions and Discussion
In this study, the significance of the p51 subunit and the C-terminal RNase 
H domain of p66 in RNA-dependent DNA synthesis by HIV-1 RT was 
investigated. A C-terminal deletion mutant, p64, was used in this investigation. 
This mutant was shown to have an Ordered Bisubstrate mechanism in its DNA 
synthesis as in the wildtype enzyme and lacks RNase H activity as described 
before (97). The deletion includes residues His539 to Leu560 which constitute a 
loop that connects (3 sheet 5 to a helix E and the entire a  helix itself as shown in 
Figure 31. Mutations at His539 have been shown to reduce both substrate 
binding and catalytic rate (105). Also, residues 534 to 545 in HIV-1 RT are the 
most highly conserved stretch of 12 amino acids in five lentivirus RNase H 
sequences as shown in Figure 32 (105). According to the crystal structure, p66 
appears to be the catalytic subunit by providing a cleft for substrate binding and 
catalysis sites for DNA polymerase and RNase H activity. However, p51 
assumes a different structure and is the non-catalytic subunit (50). The RNase H 
domain of p66 is responsible for hydrolyzing the RNA template on RNA-DNA 
duplex during DNA synthesis. Physical contact between the RNase H domain 
and the primer-template was suggested by computer modeling of HIV-1 RT and 
RNA-DNA interaction (50). It is hence important to understand the effects of the 
deletion of these conserved residues on the processivity and primer-template 
binding.
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Figure 31 C-terminal deletions in the RNase H domain of HIV-1 RT. The
amino acid sequence and the secondary structure assignments for the RNase H 
domain are shown according to the crystal structure (98). The amino acid deleted 
in the mutant enzyme ( p64 or RT4) is underlined.
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430 440 450 480
YQLEKEPIVGAETFYVDGAANRETKLGKAGYVTNKG 
I----------------- 1 I------------- 1
BETA 1 BETA 2
470 480 490
RQKVVPLTNTTNQKTELQAIYLALQDSGLEVNIVTD
I 1 I-----------------------------------1 I 1
BETA 3 HELIX A BETA 4
500 510 520 530 540
SOYAI fillOAOPDKSFSFI VNOIIEOLIKKEKVYLAWVPAHKG1
I------------1------ I--------------1 I 1
HELIX B HELIX D BETA 5
550 560
HELIX E
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Figure 32 The deletion in the mutant RT contains part of the conserved 
residues present in RNase H domains of lentiviruses. (HIV-2, human 
immunodeficiency virus type 2; SIV, simian immunodeficiency virus from 
macaque monkey; EIVA, equine infectious anemia virus; VISNA, visna lentivirus) 
These conserved residues are thought to cluster near the catalytic site (98).
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guided by the direct repeat sequence (R) on both ends of the RNA, and minus 
strand DNA synthesis proceeds to the 5' end of the RNA (PBS). The primer for 
plus strand DNA synthesis is derived from the RNA genome at a highly 
conserved region called the polypurine tract (PPT), which is located near the U3 
region at the 5' end of the minus strand DNA. The synthesis of the plus strand 
DNA is initiated from PPT and continued to the PBS of tRNA. This DNA plus 
strand is then translocated to the 3' end of the minus strand, guided by the PBS 
sequences at 3' end of both plus and minus strands. The tRNA and the primer 
for plus strand synthesis are subsequently removed by a precise RNase H 
cleavage that defines the right and left ends of the LTRs, respectively (55-57,59- 
62). The sequences of the LTRs are important for the integration of the viral 
DNA into the host cell chromosome. The LTRs also contain promoter, enhancer, 
and termination signals for gene expression. The synthesis of viral DNA is 
complete after both strands are extended to the 5' end of the complementary 
strand. The RNase H activity associated with HIV-1 RT is involved in selective 
degradation of RNA in the DNA hybrid and in generation of an RNA primer for 
synthesis of plus strand DNA (25, 43, 63-65). It is also responsible for specific 
removal of the host tRNA primer as well as the plus strand primer by specific 
cleavage at RNA-DNA junction.
The residues Pro1 through Tyr266 of HIV-1 RT are thought to be required 
for polymerase domain (47). Asp 185 and Asp186 are required in the 
polymerase active site (50). A bireactant - biproduct mechanism has been 
proposed for DNA synthesis by HIV-1 RT (66, 67). In this mechanism, binding of 
the reactants is ordered with the primer-template binding first followed by the 
binding of the 2'-deoxynucleoside 5'-triphosphate (dNTP) that is complementary 
to the next appropriate template residue as shown in Figure 5. The incorporation 
of the dNMP into the nascent chain then occurs via an Sn2 displacement of
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The dissociation constant (K<j) for poly(rA)(dT) obtained by nitrocellulose 
binding assays suggested that the processivity of HIV-1 RT on poly(rA)(dT) 
correlates with the affinity for the substrate as summarized in Table 2. These 
results support the hypothesis that p51 acts to enhance the processivity of DNA 
synthesis by improving the affinity for primer-template. It is conceivable that 
having an RNase H domain on both subunits as in the p66/p66 and p64/p64 
homodimers can cause interference in primer-template binding.
It has been proposed that the processivity of a polymerase comes from a 
tight interaction between enzymes and certain repeating motifs in the substrate; 
distributive enzymes bind to the motifs that do not repeat (103). Also, it has been 
reported that processivity numbers of HIV-1 RT can vary widely with the template 
used, increasing from a few to > 300 nucleotides (104). It is hence important to 
examine the enzyme function on templates other than poly(rA), particularly those 
with random bases instead of repeating the same base. A 335 nucleotide 
random base RNA template was then synthesized for the further studies. This 
template was hybridized with a 20 nucleotide primer (Figures 10 and 11). 
Processivity on this RNA335-DNA20 was seen to be affected by both the enzyme 
structure and pause sites as observed on the autoradiograms (Figures 22-25). In 
Figure 22, strong pause sites at 23, 24, and 38 nucleotides by p64/p64 mutant 
homodimer were observed. This C-terminal deletion mutant homodimer, which 
has a defect in RNase H function, a physical deletion in the polypeptide , and 
extra 98 residues in the non-catalytic subunit, was distributive for the first 3-5 
nucleotides incorporation. In p64/p51 (Figure 23), primers were extended to 38 
nucleotides before any major pause sites were observed. The major pause site 
at 38 nucleotides was also observed in p66/p66 as in p64/p51. However, 
p64/p51 was seen to be able to further extend the primer to 62 nucleotides. This 
observation indicates that p64/p51 is more active than p66/p66 in terms of DNA
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synthesis on RNA335-DNA20. The extra RNase H domain was seen to cause 
hindrance when comparing the primer-extension pattern by p64/p51 heterodimer 
to those by p66/p66 and p64/p64 homodimer. Also, p51 was seen to contribute 
to processivity when the primer extension patterns by p66/p66 and p66/p51 are 
compared. Although, the pause site at 38 nucleotides was also observed in 
p66/p51, the longer DNA products (74 nucleotides and more) predominated. The 
order of processivity on RNA335-DNA20 was: p66/p51> p64/p51> p66/p66> 
p64/p64. The enzyme structure was shown to play an important role in 
processivity on RNA335-DNA20 as on poly(rA)(dT). This dependence of 
processivity on enzyme structure was further studied by examining the interaction 
between RNA335-DNA20 and the different forms of enzyme.
As described above, the increases in enzyme activity and processivity on 
poly(rA)(dT) are correlated with the interaction between RT enzyme and 
po!y(rA)(dT). Alteration in enzyme structure cause changes in enzyme affinity for 
poly(rA)(dT) and hence influence the enzyme activity and processivity. It is 
conceivable that the less processive RT molecules associate with lower affinity 
for RNA335-DNA20. However, when KdS were examined (Figures 27 and 28), 
an opposite result was obtained. The p66/p51 heterodimer maintains a Kd for 
RNA335-DNA20 similar to that for poly(rA)(dT). But, p66/p66, p64/p64, and 
p64/p51 appeared to interact with RNA334-DNA20 stronger than p66/p51 and 
had higher affinity for this random base template-primer than that for 
poly(rA)(dT). Since the binding assays to determine the Kd for RNA335-DNA20 
depends on the ability of poly(rA)(dT) to trap the free RT, and poly(rA)(dT) was 
already shown to have different affinity for different forms of RT, the KdS for 
RNA335-DNA20 observed might be affected by the failure of poly(rA)(dT) to trap 
all the free RT molecules. For example, the p64/p64 has a Kd of 392 nM for 
poly(rA)(dT), and the use of poly(rA)(dT) to trap the free p64/p64 could have
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failed to prevent all the p64/p64 molecules from reassociating with RNA335- 
DNA20. This problem was prevented by using excess of poly(rA)(dT) to favor the 
formation of RT-poly(rA)(dT) complex. In a control reaction where RT, 
poly(rA)(dT), and RNA335-DNA20 were incubated at the same time before the 
reaction was initiated, the amount of poly(rA)(dT) used was shown to be able to 
trap RT. The [32P]-labeled primer in this control reaction was poorly extended as 
judged by the autoraiogram. The tight interaction between random RNA 
template-primer and the non-wildtype enzyme was further observed when 
RNA335-DNA12 was used to study the effect of primer length on enzyme affinity 
for substrate (Figure 29). As summarized in Table 3, the non-wildtype RT 
molecules have smaller K<jS for random base RNA template-primer than the 
p66/p51 wildtype enzyme.
Table 3 Summary of the measured dissociation constants (nM) of 
HIV-1 RT for random base RNA template-primer.








The p64/p51 molecules appeared to have stronger interaction with RNA335- 
DNA12 than RNA335-DNA20. However, the wildtype enzyme, p66/p51, 
demonstrated a weaker affinity for RNA335-DNA12 than for RNA335-DNA20.
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This result was similar to that observed by Beard (74). In his studies, short oligo 
(dT) primers (less than 14 nucleotides), annealed to poly(rA), bound RT relatively 
weakly (Kd = 2 0 - 3 0  nM), whereas oligo (dT) primers of 16 and 20 nucleotides in 
length bound tightly to RT (Kd -  0.1 nM). The results of the binding assays 
suggest the processivity on RNA335-DNA20 does not depend on the dissociation 
constant of RT for this template-primer. The tight interaction observed could be 
because the substrate binding in those non-wildtype enzymes is more sensitive 
to the nature of the primer-template. Strong premature termination was seen in 
the primer extension on RNA335-DNA20 by the non-wildtype enzyme. This 
observation suggests that these RT molecules, after binding and short extending 
the primer, either dissociate from and lose affinity for the primer-template or 
remain bound to the primer-template without any further extension. A “stall" 
mechanism has been proposed to explain the premature termination in DNA 
synthesis by HIV-1 RT (78). This mechanism suggested that the enzyme 
remains bound strongly to the primer-template and allows no further DNA 
synthesis.
The pauses of DNA synthesis tended to occur at template positions 
containing poly G,C sequences as shown in Figure 30. This dependency of 
pause sites on template sequence was confirmed by using a 12-mer and a 25- 
mer as primer which have the same 5‘ termini of the 20-mer. The major pause 
site, 38-mer, was seen to be independent of the position of the 3' end of the 
primer but dependent on the template sequence. The template sequence 
flanking the pause sites are shown in Figure 33. The G-C sequence dependence 
of the pause sites is an important area to study to elucidate why HIV-1 RT can 
catalyze synthesis over all the G-C rich stretches in its RNA genome to complete 
the transcription. Mutations might be required for RT to transcribe over these G- 
C rich pause sites. Furthermore, an auxiliary viral or cellular factor might be
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Figure 33 The template sequences around the pause sites for DNA 
synthesis by HIV-1 RT on RNA335-DNA20. The length of the paused product 
and seven bases upstream and down stream the pause site are shown. The poly 
G or C stretches are underlined.




SS template dS Stem
7 6 5 4 3 2 1 0 1 2 3 4 5 6 7
20 A U A U C A A G C U U A U C G
23 U G C A U A U C A A G C U U A
24 U U G C A U A U C A A G C U U
25 A U U G C A U A U C A A G C U  
38  C C G G G C U G C A G G A A U
43 A U C C C C C G G G C  U G C A
44 G A U C C C C C G G G C  U G C
62 G C C G C U C U A G A A C U A
65 G C G G C C G C U C U A G A A
74 A C C G C G G U G G C G G C C
5'
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involved in the process. The G-C rich stretches are likely forming secondary 
structure through intra- or intermolecular interaction between G and C bases and 
hence blocking the DNA synthesis. It is also possible that HIV-1 RT contains 
substrate binding subsites for the RNA template, similar to those known for 
RNase A and that these subsites happen to have strong affinity for G and C 
bases. If this hypothetical subsite scenario is correct, then polymerization 
proceeds across the RNA template in a processive fashion through AT rich 
areas. However, when HIV-1 RT encounters several G and C bases in a row, 
most of the subsites interact with G or C and hence lock the primer-template. 
The DNA synthesis is then terminated by the "stall" mechanism described above. 
On the other hand, it is also possible that the subsites have very loose affinity for 
G and C and the termination of DNA synthesis is a consequence of the loose 
interaction between enzyme and G-C rich areas of the primer-template. HIV-1 
RT falls off the primer-template and fails to extend the primer over the G-C rich 
template.
The processivity data of p64/p51 and p66/p51 showed that the C-terminal 
deletion can reduce the processivity of DNA synthesis on both poly(rA)(dT) and 
RNA335-DNA20. Since the mutant enzyme still maintains its Ordered 
Bisubstrate mechanism in DNA synthesis, this 22 amino acid deletion in the 
RNase H domain does not affect the assembly of the functional polymerase 
domain, but it is important in processivity. Similar results were observed in a 
Gln475Glu mutant of HIV-1 RT which has retarded RNase H function (107). In 
the primer extension study, the primers were not extended by p64/p51 as well as 
they were by p66/p51. A catalytically functional RNase H domain is hence 
required to facilitate processive DNA synthesis and reinitiation of the DNA 
synthesis at specific pause sites. The role of the RNase H activity in facilitating 
DNA synthesis was also observed by Dudding et al. (90). However, as seen in
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the processivity and primer extension data by p66/p66, although a functional 
RNase H domain was present in the homodimer, the processivity was still 
reduced and the primer was not well extended. It is likely the extra RNase H 
domain in the non-catalytic subunit causes hindrance to DNA synthesis. It is also 
possible that the folding of the non-catalytic p66 is less capable of maintaining 
the favorable enzyme conformation than p51 in the wildtype.
It is hoped that the knowledge of structure-function relationships of HIV-1 
RT will facilitate the design of new inhibitors of this enzyme and suggest 
strategies that might help to circumvent the ability of mutant RT molecules to 
escape the potency of inhibitors. In this investigation, the p51 subunit is seen to 
contribute significantly to enzyme activity and processivity of HIV-1 RT. The 
extra RNase H domain in the small subunit can decrease the enzyme function, 
as seen in p66/p66 and p64/p64. The p51 subunit, although harbors no catalytic 
sites, plays an important role in maintaining the favorable conformation of the 
enzyme. Hence, molecules that can disrupt the interaction between subunits are 
potential HIV-1 RT inhibitors. The C-terminal deletion in p64/p51 causes 
decreases in enzyme activity and processivity. Since the HIV-1 RT DNA 
polymerase activity is correlated with its RNase H domain, inhibitors that can 
affect the RNase H function or alter its conformation can be useful in blocking the 
DNA synthesis. G-C rich sequences of RNA template is shown to be able to 
command the RT to pause the DNA polymerization. Introduction of molecules 
that can prevent the RT from reinitiating the DNA synthesis on these pause sites 
is hence one of the antiviral strategies.
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APPENDIX 1
A. pBluescript (+) sequence for generating the 446 bp DNA fragment
530 540 550 560 570
*  •  •  •  •
GCTG GCGAA GGGGG GATGT GCTGC AAGGC GATTA AGTTG GGTAA CGCCA 
PCR primer 1
580 590 600 610 620
•  *  *  *  *
GGGTT TTCCC AGTCA CGACG TTGTA AAACG ACGCC CAGTG AATTG TAATA
T 7
630 640 650 660 670
*  •  *  *  *
CGACT CACTA TAGGG CGAAT TGGAG CTCCA CCGCG GTGGC GGCCG CTCTA 
Promoter +1
680 690 700 710 720
*  *  *  i  •
GAACT AGTGG ATCCC CCGGG CTGCA GGAAT TCGAT ATCAA GCTTA TCGAT
730 740 750 760 770
•  *  *  *  *
ACCGT CGACC TCGAG GGGGG GCCCG GTACC CAGCT TTTGT TCCCT TTAGT
780 790 800 810 820
*  •  *  *  *
GAGGG TTAAT TCCGA GCTTG GCGTA ATCAT GGTCA TAGCT GTTTC CTGTG
830 840 850 860 870
*  *  *  *  •
TGAAA TTGTT ATCCG CTCAC AATTC CACAC AACAT ACGAG CCGGA AGCAT
880 890 900 910 920
*  *  *  *  *
AAAGT GTAAA GCCTG GGGTG CCTAA TGAGT GAGGT AACTC ACATT AATTG
930 940 950 960 970
*  *  *  *  *
CGTTG CGCTC ACTGC CCGCT TTCCA GTCGG GAAAC CTGTC GTGCC AG
GCC CTTTG GACAG CACGG TC 
PCR primer 2
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APPENDIX 2
B. Sequence of the random base RNA template
10 20 30 40 50
*  *  *  *  *
GGGCG AAUUG GAGCU CCACC GCGGU GGCGG CCGCU CUAGA ACUAG UGGAU
60 70 80 90 100
•  •  *  •  *
CCCCC GGGCU GCAGG AAUUC GAUAU CAAGC UUAUC GAUAC CGUCG ACCUC
CG AATAG CTATG GCAGC TGG 5'
20-MER
110 120 130 140 150
*  *  *  *  *
GAGGG GGGGC CCGGU ACCCA GCUUU UGUUC CCUUU AGUGA GGGUU AAUUC
160 170 180 190 200
•  •  *  •  *
CGAGC UUGGC GUAAU CAUGG UCAUA GCUGU UUCCU GUGUG AAAUU GUUAU
210 220 230 240 250
* * * * *
CCGCU CACAA UUCCA CACAA CAUAC GAGCC GGAAG CAUAA AGUGU AAAGC
260 270 280 290 300
•  *  *  *  *
CUGGG GUGCC UAAUG AGUGA GGUAA CUCAC AUUAA UUGCG UUGCG CUCAC
310 320 330
*  *  *
UGCCC GCUUU CCAGU CGGCA AACCU GUCGT GCCAG
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